期刊文献+

组蛋白去乙酰化调控与乳腺癌关系的研究进展 被引量:2

下载PDF
导出
出处 《实用癌症杂志》 2007年第4期423-424,427,共3页 The Practical Journal of Cancer
  • 相关文献

参考文献38

  • 1Grunstein M.Histone acetylation in chromatin structure and transcription[J].Nature,1997,389:349. 被引量:1
  • 2Fu XH,Liu DP,Liang CC.Chromatin structure and transcriptional regulation of the β-globin locus[J].Exp Cell Res,2002,278(1):1. 被引量:1
  • 3Berger SL.Histone modifications in transcriptional regulation[J].Curr Opin Genet,2002,12:142. 被引量:1
  • 4Marks PA,Rifkind RA,Richon VM,et al.Histone deacetylases and cancer:causes and therapies[J].Nat Rev Cancer,2001,1(3):194. 被引量:1
  • 5Jenuwein T,Allis CD.Translating the histone code[J].Science,2001,293 (5532):1074. 被引量:1
  • 6Yang XJ,Serge G.Class Ⅱ histone deacetylases:from sequence to function,regulation and clinical implication[J].Mol Cell Biol,2005,25(6):2873. 被引量:1
  • 7Bernstein BE,Tong JK,Schreiber SL.Genome wide studies of histone deacetylase function in yeast[J].Proc Natl Acad Sci USA,2000,97 (25):13708. 被引量:1
  • 8Bjerling P,Silverstein RA,Thon G,et al.Functional divergence between histone deacetylases in fission yeast bydistinct cellular localization and in vivo specificity[J].Mol Cell Biol,2002,22(7):2170. 被引量:1
  • 9Fischer DD,Cai R,Bhatia U,et al.Isolation and characterization of a novel class Ⅱ histone deacetylase,HDAC10[J].J Biol Chem,2002,277 (8):6656. 被引量:1
  • 10Gao L,Cueto MA,Asselbergs F,et al.Cloning and functional characterization of HDAC11,a novel member of human histone deacetylase family[J].J Biol Chem,2002,277 (28):25748. 被引量:1

二级参考文献129

  • 1谢爱华,廖晨钟,李伯玉,山松,邓沱,李志斌,宁志强,胡伟明,石乐明,周家驹,鲁先平.以组蛋白去乙酰化酶为靶标的抗癌药物研发进展[J].中国新药杂志,2005,14(1):10-14. 被引量:8
  • 2[1]Chambers AE, Banerjee S, Chaplin T, et al. Histone acetylation-mediated regulation of genes in leukaemic cells [J].Eur J Cancer, 2003, 39(8): 1165-1175. 被引量:1
  • 3[2]Jay L'Grisolano, Julie O'Neal, Jennifer Cain, et al. An activated receptor tyrosine kinase, TEL/PDGFβR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice[J]. Medical Sciences, 2003,100(16):9506-9511. 被引量:1
  • 4[3]Hong J, Ishihara K, Yamaki K, et al. Apicidin,a histone deacetylase inhibitor, induces differentiation of HL-60 cells[J].Cancer Lett, 2003, 189(2):197-206. 被引量:1
  • 5[4]Lorincz MC, Schubeler D, Groudine M. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation[J]. Mol Cell Biol, 2001, 21(23):7913-7922. 被引量:1
  • 6[5]Lea MA, Randolph VM, Patel M. Increased acetylation of histion induced by dially1 disulfide and structurally related molecules[J]. Int J Oncol,1999,15(2):347-352. 被引量:1
  • 7[6]Puccetti E, Obradovic D, Beissert T, et al. AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor[J].Cancer Res, 2002, 62(23):7050-7058. 被引量:1
  • 8[7]Ferrara FF, Fazi F, Bianchini A, et al. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia[J]. Cancer Res, 2001,61(1):2-7. 被引量:1
  • 9[8]Lea MA, Rasheed M, Randolph VM, et al. Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine [J]. Nutr Cancer, 2002, 43(1):90-102. 被引量:1
  • 10[9]Wittich S, Scherf H, Xie C, et al. Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells[J]. J Med Chem, 2002, 45(15):3296-3309. 被引量:1

共引文献63

同被引文献23

  • 1JORDAN V C. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions [ J]. J Med Chem,2003,46(6) : 883-908. 被引量:1
  • 2JORDAN V C. Antiestrogens arid selective estrogen receptor modulators as multifunctional medicines, clinical considerations and new agents [ J ]. J Med Chem, 2003,46 (7) : 1081-1111. 被引量:1
  • 3ARIAZI E A, ARIAZ! J L, CORDERA F, et al. Estrogen receptors as therapeutic targets in breast cancer [ J ]. Curt Top Med Chem,2006,6(3) : 181-202. 被引量:1
  • 4HORTOBAGYI G N. Treatment of breast cancer [ J]. N Engl J Med, 1998,339(14) : 974-984. 被引量:1
  • 5VAN LEEUWEN F E,BENRAADT J, COEBERGH J,et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer [ J]. Lancet, 1994,343(8895) : 448-452. 被引量:1
  • 6PASQUALINI J R, MERCAT P, GIAMBIAGI N. Histone acetylation decreased by estradiol in the MCF-7 human mammary cancer cell line [ J ]. Breast Cancer Res Treat, 1989,14 (1) : 101-105. 被引量:1
  • 7PARK S Y,JUN J A, JEONG K T, et al. Histone deacetylases 1,6 and 8 are critical for invasion in breast cancer [J]. Oncol Rep,2011,25(6) : 1677-1681. 被引量:1
  • 8MARGUERON R, DUONG V, BONNET S, et al. Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens [ J ]. J Mol Endocrinol, 2004,32 (2) : 583-594. 被引量:1
  • 9REID G, METIVIER R. LIN C Y, et al. Multiple mechanisms induce transcriptional silencing of a subset of genes,including oestrogen receptor alpha, in response to deacetylase inhibition by valproie acid and trichostatin A [J ]. Oncogene, 2005,24 ( 31 ) : 4894-4907. 被引量:1
  • 10MARKS P A. Discovery and development of SAHA as an anticancer agent [ J ]. Oncogene, 2007, 26 (9) : 1351- 1356. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部